Get notified of page updates
Sign Up for FORCE Newsletters
Public Policy Priorities
Review some of FORCE's current legislative and regulatory policy priorities that impact the hereditary cancer community.
I am here to learn about:
Close

Genetic Testing

I've Tested Positive, Now What?

Women with Mutations

Men with Mutations

Lynch Syndrome

Colorectal Cancer

Ovarian Cancer

Breast Cancer

Pancreatic Cancer

Prostate Cancer

Endometrial Cancer

Biomarker Testing

Information for Healthcare Professionals

Information for Researchers

Managing Menopause

Family History and Outreach

Resources to Address Health Disparities

LGBTQIA+ and Cancer

Español

Privacy, Policy and Legal Issues > Advocacy Archive > Archived Policy

Policy Archive

Statement Sets the Record Straight on AHCA and HR 1313

Insurance Coverage & Barriers

May 2017 - Recent events related to proposed changes in health care and genetic privacy laws have spurred concern and uncertainty in the hereditary cancer community. Some media stories have disseminated inaccurate information, which has intensified people's unease. We prepared this briefing to dispel some of the misinformation and allay some of the fears that have been expressed by members of our community.

This statement aims to answer questions and clarify information regarding the Preserving Employee Wellness Programs Act (HR 1313), employer-based wellness programs, and the Genetic Information Nondiscrimination Act (GINA). It also explains where things stand with repeal and replacement of the Affordable Care Act (ACA), and clarifies what may be considered a pre-existing condition. We encourage you to share this with friends and family in the hereditary cancer community. Please check back regularly for updates as policies on these and other issues are considered.

Statement on Health Care and Genetic Privacy

Take Action Now BECOME AN ADVOCATE 2023 Priorities Advocacy Archive Public Policy Initiatives

News Briefs

8/14/2023 - Joined stakeholders in a letter to the American College of Physicians expressing disappointment with the preventive colorectal cancer screening guidance it published, which conflicts with recommendations provided by the USPSTF, NCCRT, ACS, NCCN and other reputable organizations. 

7/21/2023 - Wrote House and Senate leadership, expressing support for increased funding for the Agency for Healthcare Research and Quality (AHRQ) in its staffing and administrative support of the U.S. Preventive Services Task Force (USPSTF) as part of the FY24 appropriations bill.

6/7/2023 - Joined physicians and patient advocacy groups to support California AB 632, which will allow patients to receive prostate cancer screening without a deductible, copayment, or coinsurance for prostate cancer screening, including men over the age of 40 who are at high risk for prostate cancer.

More

Related Resources
Related Resources